drugset / Trial / NCT01312324
Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
NaSingle-groupOpen-labelTreatment
Summary
We try to evaluate whether neoadjuvant docetaxel plus cisplatin can increase the complete resection rate in advanced thymic carcinoma.
Timeline
- Start
- 2007-02
- Primary completion
- 2015-07
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | — |